We are pleased to share an exciting PhD opportunity at Erasmus MC. The project focuses on integrating causal inference, surrogate marker evaluation, and joint models for longitudinal and event-time data to validate minimal residual disease as a surrogate endpoint in clinical trials for patients with hematologic malignancies.
Further details about the position and the application process are available here:
